Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Oral Tecovirimat in Healthy Subjects
NCT02474589Phase 3Completed
- Sponsor
- SIGA Technologies
- Start
- Jun 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tecovirimat in smallpox, sponsored by SIGA Technologies. Started Jun 2015; status: completed.
02
Drugs
tecovirimat
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT02474589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474589.